Overview

25-Hydroxyvitamin D Pharmacokinetic Study

Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacokinetic parameters of orally administered 25-hydroxyvitamin D3 [25(OH)D3] and vitamin D3 from the corresponding serum concentration-time curves in healthy adults and adults with a history of intestinal malabsorption.
Phase:
Early Phase 1
Details
Lead Sponsor:
Boston University
Treatments:
Calcifediol
Cholecalciferol
Ergocalciferols
Hydroxycholecalciferols
Vitamin D
Vitamins